Shanghai Lanmai Medical Technology Co., Ltd. announced that it will receive CNY 60,000,000 in an equity round of funding on July 7, 2020. The transaction will include participation from returning investor Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHSE:688016). After the completion of the transaction, the registered capital of the company will increase from CNY 5,000,000 to CNY 65,000,000. The investor will retain 100% stake in the company. The transaction got approved by the supervisory board of Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHSE:688016) at the eighth meeting of the first board of supervisors.